These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20608876)

  • 1. Prostate cancer gene therapy: attempts to innovate.
    Kochanek S; Gansbacher B
    Hum Gene Ther; 2010 Jul; 21(7):791. PubMed ID: 20608876
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene-based therapy in prostate cancer.
    Foley R; Lawler M; Hollywood D
    Lancet Oncol; 2004 Aug; 5(8):469-79. PubMed ID: 15288235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer gene therapy: past experiences and future promise.
    Gardner TA; Sloan J; Raikwar SP; Kao C
    Cancer Metastasis Rev; 2002; 21(2):137-45. PubMed ID: 12465753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current challenges of gene therapy for prostate cancer.
    Harrison GS; Glode LM
    Oncology (Williston Park); 1997 Jun; 11(6):845-50, 856; discussion 856-8, 861. PubMed ID: 9189941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific promoters in gene therapy for the treatment of prostate cancer.
    Shirakawa T; Gotoh A; Wada Y; Kamidono S; Ko SC; Kao C; Gardner TA; Chung LW
    Mol Urol; 2000; 4(2):73-82. PubMed ID: 12006246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel combined therapy for prostate cancer proves significantly more effective.
    Oncology (Williston Park); 2006 Jun; 20(7):785. PubMed ID: 16841800
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions.
    Pantuck AJ; Zisman A; Belldegrun AS
    World J Urol; 2000 Apr; 18(2):143-7. PubMed ID: 10854150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy of prostate carcinoma].
    Brill T; Barba M; Breul J; Gänsbacher B
    Internist (Berl); 2001 Oct; 42(10):1328-36, 1339-40, 1342-5. PubMed ID: 11688152
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancer.
    Pantuck AJ; Belldegrun AS
    Curr Urol Rep; 2001 Feb; 2(1):33. PubMed ID: 12084292
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene therapy].
    Watanabe M; Sadahira T; Nasu Y
    Nihon Rinsho; 2016 May; 74 Suppl 3():221-5. PubMed ID: 27344732
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy for prostate cancer.
    Bower M; Waxman J
    Semin Cancer Biol; 1997 Feb; 8(1):3-9. PubMed ID: 9299576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide gene therapy for urogenital cancer: current outcome and prospects.
    Nasu Y; Kusaka N; Saika T; Tsushima T; Kumon H
    Mol Urol; 2000; 4(2):67-71. PubMed ID: 12006245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.
    Martiniello-Wilks R; Wang XY; Voeks DJ; Dane A; Shaw JM; Mortensen E; Both GW; Russell PJ
    J Gene Med; 2004 Dec; 6(12):1343-57. PubMed ID: 15493036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer.
    Lu Y
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):572-88. PubMed ID: 19393705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical biodistribution and safety study of reduced expression in immortalized cells/Dickkopf-3-encoding adenoviral vector for prostate cancer gene therapy.
    Sugimoto M; Watanabe M; Kaku H; Li SA; Noguchi H; Ueki H; Sakaguchi M; Huh NH; Nasu Y; Kumon H
    Oncol Rep; 2012 Nov; 28(5):1645-52. PubMed ID: 22941469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different approaches of gene therapy used in prostate cancer.
    Ghosh A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):103-11. PubMed ID: 16171569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypurine reverse Hoogsteen hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivo.
    Rodríguez L; Villalobos X; Dakhel S; Padilla L; Hervas R; Hernández JL; Ciudad CJ; Noé V
    Biochem Pharmacol; 2013 Dec; 86(11):1541-54. PubMed ID: 24070653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of prostate gene expression to develop targeted therapies.
    Maitland NJ
    Acta Biomed; 2003 Aug; 74(2):105-6. PubMed ID: 14509921
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy for prostate cancer.
    Gingrich JR; Chauhan RD; Steiner MS
    Curr Urol Rep; 2001 Jun; 2(3):199-208. PubMed ID: 12084265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.
    Satoh T; Timme TL; Saika T; Ebara S; Yang G; Wang J; Ren C; Kusaka N; Mouraviev V; Thompson TC
    Hum Gene Ther; 2003 Jan; 14(2):91-101. PubMed ID: 12614561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.